#Trade Shows & Events
Gathering Momentum, Empowering the Future: The 2nd National Medical Investment & Commercialization Elite Summit Successfully Held at Dukon Industrial Park
Over 200 medical industry leaders gather at Dukon Industrial Park to advance non-invasive brain stimulation technology, channel synergy, and integrated neurorehabilitation.
SHIJIAZHUANG, CHINA — July 13, 2026 — On July 10, 2026, the 2nd National Medical Commercialization & Investment Elite Empowerment Summit (Hebei Station) was successfully held at the Dukon Health Technology Industrial Park. Co-hosted by Hongyihui (Beijing) Consulting Service Co., Ltd. and Shijiazhuang Dukon Medical Instruments Co., Ltd., the summit brought together more than 200 channel distributors, regional agents, and medical device investment managers from across China.
Centered on the core theme of "Gathering Momentum for Empowerment & Win-Win Cooperation," the conference addressed industry restructuring, centralized procurement trends, and market expansion. Attendees explored new commercialization pathways across three major product sectors: General Surgery, Laboratory Pathology, and Traditional Chinese Medicine (TCM) Rehabilitation.
Uniting Industry Leaders to Drive High-Quality Rehabilitation Care
As co-host, Shijiazhuang Dukon Medical Instruments Co., Ltd. reiterated its founding vision: "Focusing on Brain Rehabilitation, Empowering Healthy Lives." Dukon continues to deepen its presence in total rehabilitation planning and advanced R&D, delivering overall solutions across six specialized units:
Neurological Rehabilitation
Mental Health Rehabilitation
Pediatric Rehabilitation
TCM Rehabilitation
Home Rehabilitation
Critical Care (ICU) Rehabilitation
Dukon Medical has established a core product portfolio powered by non-invasive brain stimulation and neuromodulation technologies. Key flagship product series include:
Repetitive Transcranial Magnetic Stimulation (rTMS) Systems
Transcranial Direct Current Stimulation (tDCS) Devices
Transcranial Ultrasonic Electrotherapy Devices
Brain Reflex & EEG Therapy Systems
Today, Dukon's clinical network spans over 6,000 secondary and tertiary medical institutions and supports 400,000+ families worldwide.
Keynote Insights: Policy Trends, Innovation, and Channel Synergy
Industry leaders delivered keynote speeches focusing on regulatory policies, market trends, and channel ecosystem development:
Zhu Zengqi, Former Director of the Medical Device Division at the Shijiazhuang Food and Drug Administration, shared policy insights on medical device compliance and growth.
Li Luochen, Vice Chairman and Secretary-General of the Hebei Biomedical Engineering Society, highlighted the acceleration of clinical technology translation.
Li Bin, General Manager of Dukon Medical, outlined Dukon's commitment to building open, collaborative partner networks.
Huofenghuang, Founder of Hongyihui, presented a featured lecture on modern medical device investment models, channel expansion, and resource integration.
The speakers emphasized that under ongoing healthcare reforms, upstream manufacturers and downstream channel partners must strengthen collaboration to accelerate the adoption of high-quality, innovative medical devices in hospitals and primary care settings.
Strategic Upgrade: From Equipment Manufacturer to Integrated Solution Provider
During the keynote presentations, Li Zhichao, Vice General Manager of Dukon Medical, detailed the company’s strategic transformation.
"In response to the rapid evolution of the neurorehabilitation sector, Dukon Medical is actively executing a strategic upgrade—transitioning from a single rehabilitation equipment manufacturer into a full-scope, integrated rehabilitation center solution provider," stated Mr. Li.
To support this evolution, Dukon is accelerating the development of the Dukon Health Technology Industrial Park—a modern 60,000-square-meter manufacturing and R&D hub designed to integrate innovation, intelligent manufacturing, clinical translation, and academic exchange.
Interactive Product Demonstrations & Collaborative Networking
The summit featured interactive product roadshows, clinical case studies, and business match-making sessions. Dukon’s non-invasive brain stimulation solutions—particularly its rTMS, tDCS, and Transcranial Ultrasonic lines—drew significant attention from visiting channel partners, leading to on-site consultations regarding regional distribution agreements.
To foster engaged communication, the event concluded with open networking sessions and a interactive prize draw, where the grand prize was Dukon’s flagship Home-Care Portable rTMS Therapy Device.
Looking Ahead
Driven by technological innovation and clinical demand, Dukon Medical remains dedicated to empowering global partners and advancing brain health. Moving forward, Dukon will continue to expand its open ecosystem, bringing advanced non-invasive neuromodulation technologies into more hospitals, community health centers, and home care environments.
Executive Summary
Event: 2nd National Medical Commercialization & Investment Elite Empowerment Summit (Hebei Station)
Date & Location: July 10, 2026 | Dukon Health Technology Industrial Park, Shijiazhuang, China
Hosts: Hongyihui (Beijing) Consulting Service Co., Ltd. & Shijiazhuang Dukon Medical Instruments Co., Ltd.
Key Highlights: 200+ industry executives gathered; Dukon showcased its strategic transition into an integrated rehabilitation center solution provider; highlighted non-invasive brain stimulation systems (rTMS, tDCS, Ultrasonic Electrotherapy).
